A novel liquid chromatography with quadrupole time-of-flight-tandem mass spectroscopy method for ultra-trace level identification and quantification of the genotoxic impurity 2,6-diamino-5-nitropyrimidin-4(3H)-one in valganciclovir hydrochloride

被引:6
作者
Ali, Shaik Mahammad [1 ]
Moorthy, Manchuri Krishna [1 ]
Devanna, Nayakanti [2 ]
机构
[1] Jawaharlal Nehru Technol Univ Anantapur, Dept Chem, Ananthapuramu 515002, Andhra Pradesh, India
[2] JNTUA Coll Engn, Dept Chem, Kalikiri, Andhra Pradesh, India
关键词
2,6-diamino-5-nitropyrimidin-4(3H)-one (DMNP); fragmentation; liquid chromatography-quadrupole time-of-flight-tandem mass spectroscopy (LC-QTOF-MS/MS); ultra-trace level quantification; valganciclovir hydrochloride (VAL) genotoxic impurity;
D O I
10.1002/bmc.5805
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, the main objective is to develop an analytical method for ultra-trace level measurement of 2,6-diamino-5-nitropyrimidin-4(3H)-one (DMNP) in valganciclovir hydrochloride (VAL) using liquid chromatography-quadrupole time-of-flight-tandem mass spectroscopy (LC-QTOF-MS/MS). In the early stages of guanine synthesis, DMNP is formed, and guanine is known to be the key starting material for the synthesis of VAL. Taking into consideration DMNP potential genotoxicity, this analytical method has been developed. This method is time saving and suitable for confirming the masses of parent and fragment ions by MS and MS/MS further fragmentation. An isocratic program and Acquity UPLC HSS cyano column (100 x 2.1 mm x 1.8 mu m) were used to achieve optimal separation between VAL and the DMNP impurity. A 0.1% ammonia solution in Milli-Q water was used as mobile phase A, and methanol was used as mobile phase B in the ratio 90:10 v/v in isocratic mode. In accordance with the International Conference on Harmonization's requirements, the developed method was validated. The detection and quantification levels were found to be 0.028 and 0.083 ppm respectively. The DMNP impurity is linear from 0.083 to 1.245 ppm levels with correlation coefficient (R2) of 0.9960. The recoveries were found to be 97.0-107.9%.
引用
收藏
页数:10
相关论文
共 26 条
  • [1] Development of non-aqueous titrimetric and spectrophotometric methods for the determination of valganciclovir hydrochloride in bulk drug and tablets
    Abdulrahman, S. A. M.
    Algethami, F. K.
    Qarah, N. A. S.
    Basavaiah, K.
    El-Maaiden, E.
    [J]. ANNALES PHARMACEUTIQUES FRANCAISES, 2021, 79 (05): : 489 - 499
  • [2] Therapeutic drug monitoring and LC-MS/MS
    Adaway, Joanne E.
    Keevil, Brian G.
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 883 : 33 - 49
  • [3] Carcinogenicity categorization of chemicals - new aspects to be considered in a European perspective
    Bolt, HM
    Foth, H
    Hengstler, JG
    Degen, GH
    [J]. TOXICOLOGY LETTERS, 2004, 151 (01) : 29 - 41
  • [4] Development and validation of an RP-HPLC method for determination of valganciclovir in human serum and tablets
    Dogan-Topal, B.
    Uslu, B.
    Ozkan, S. A.
    [J]. CHROMATOGRAPHIA, 2007, 66 (Suppl 1) : S97 - S101
  • [5] Design of experiments in liquid chromatography (HPLC) analysis of pharmaceuticals: analytics, applications, implications and future prospects
    Ganorkar, Saurabh B.
    Shirkhedkar, Atul A.
    [J]. REVIEWS IN ANALYTICAL CHEMISTRY, 2017, 36 (03)
  • [6] Determination of Ganciclovir and its prodrug Valganciclovir by hydrophilic interaction liquid chromatography-tandem mass spectrometry
    Heinig, Katja
    Wirz, Thomas
    Gajate-Perez, Almudena
    Belli, Sara
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (5-6): : 436 - 442
  • [7] Toxicological overview of impurities in pharmaceutical products
    Jacobson-Kram, David
    McGovern, Timothy
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (01) : 38 - 42
  • [8] Karthick K., 2020, IJCPA, V7, P1
  • [9] Konidala S.K., 2014, World J. Pharm. Res., V3, P4773
  • [10] Development of a RP-LC method for a diastereomeric drug valganciclovir hydrochloride by enhanced approach
    Kumar, R. Suresh
    Hariram, B.
    Divya, G.
    Srinivasu, M. K.
    Srinivas, Katkam
    Sagyam, Rajeshwar Reddy
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 70 : 101 - 110